Lundbeck and ImaginAb pair in neurodegeneration Rx/Dx
This article was originally published in Scrip
Executive Summary
Lundbeck has signed a deal with Los Angeles-based ImaginAb aimed at marrying molecular imaging and the development of biologic therapies in the field of neurodegeneration.